Clinical Trial to Evaluate Efficacy and Safety of ROVASRO 10mg Versus CRESTOR 10mg in Hypercholesterolemic Patients
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 126 participants.
Also called NCT03949374
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 126 participants
- Sponsor
- Registry
-
NCT03949374
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- South Korea
- Registry status
- Completed
Technical summary
Registry record NCT03949374. Randomized; no masking; primary purpose treatment. Start 2015-10-23 (actual); primary completion 2018-04-16 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Clinical Trial to Evaluate Efficacy and Safety of ROVASRO 10mg Versus CRESTOR 10mg in Hypercholesterolemic Patients
- Condition
- Hypercholesterolemia
- Condition
- Dyslipidemias
- Intervention (Drug)
- CRESTOR, reference formulation of rosuvastatin
- Intervention (Drug)
- ROVASRO, generic formulation of rosuvastatin
- Lead sponsor
- Yonsei University
Record details
- Record id
cardio:ct-nct03949374- Content hash
ef16a3c04a259b3481fc309b6e355411e8a78d8e0fa80a54dfe177b1c9026458